Skip to main content
Saurabh Chhabra, MD, Oncology, Scottsdale, AZ

Saurabh Chhabra MD MS

Oncology•Scottsdale, AZ

Hematologic Oncology

Consultant, Mayo Clinic, Phoenix, AZ

Join to view full profile

  • 13400 E Shea BlvdScottsdale, AZ 85259

  • Phone+1 480-301-8000

Dr. Chhabra is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Chhabra's full profileAlready have an account?

Summary

  • Dr. Saurabh Chhabra is an oncology specialist based in Scottsdale, AZ, with expertise in hematologic oncology. He completed his medical education at Delhi University College of Medical Sciences and went on to complete fellowships in Hematology, Medical Oncology, and Blood & Bone Marrow Transplantation at prestigious institutions including Stanford Health Care and Rutgers Health. Dr. Chhabra currently serves as a Professor of Medicine at Mayo Clinic Arizona and has previous academic appointments at the Medical College of Wisconsin and MUSC Health. His clinical experience includes amyloidosis, myelodysplasia, and hematopoietic stem cell transplantation. He has contributed over 200 publications to the field, focusing on CAR-T cell therapy and stem cell transplantation (>10,000 citations). Dr. Chhabra has been involved in clinical trials related to multiple myeloma, including CAR-T cell therapies, bispecific and trispecific antibodies and allogeneic stem cell transplantation. His work has been recognized with CMS Meaningful Use Certifications from Epic Systems Corporation.

Education & Training

  • CTSI of Southeastern Wisconsin
    CTSI of Southeastern WisconsinM.S., CTS, 2016 - 2018
  • Stanford Health Care
    Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 2011 - 2012
  • Rutgers Health/Robert Wood Johnson Medical School
    Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Rutgers Health/Robert Wood Johnson Medical School
    Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2006 - 2008
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 2005 - 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2028
  • AZ State Medical License
    AZ State Medical License 2022 - 2027
  • SC State Medical License
    SC State Medical License 2012 - 2027
  • WI State Medical License
    WI State Medical License 2016 - 2027
  • NJ State Medical License
    NJ State Medical License 2008 - 2011
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Second Primary Malignancy After Multiple Myeloma‐Population Trends and Cause‐Specific Mortality  
    Parameswaran Hari, Luciano J Costa, Saurabh Chhabra, Kelly N Godby, British Journal of Haematology

Abstracts/Posters

  • Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizu...
    Saurabh Chhabra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)
    Saurabh Chhabra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...
    Saurabh Chhabra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Weighing Conditioning Regimens for Patients with CML Undergoing Transplant
    Weighing Conditioning Regimens for Patients with CML Undergoing TransplantJanuary 1st, 2019

Professional Memberships

  • American Society of Hematology
    Member
  • American Society of Blood and Marrow Transplantation
    Member

Other Languages

  • Hindi

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Saurabh Chhabra, Dr. Saurabh Chhabra, MD, Dr. S Chhabra